Could Low-Dose THC Slow Brain Aging? What a New Study Found

Intriguing results in aged mice — and why the details matter.

Could a low dose of THC help keep an aging brain sharp? A study from researchers in Germany and Israel has produced some genuinely intriguing findings — and the authors suggest their work could one day inform anti-aging and cognition-supporting medications. As always with early research, the details matter, so it's worth understanding both what the study showed and what it didn't.

What the Study Did

The research, published in ACS Pharmacology & Translational Science, was carried out by teams from University Hospital Bonn and the University of Bonn together with Hebrew University in Israel, with funding from the German Research Foundation. The researchers gave young mice (about four months old) and old mice (about 18 months old) either a daily low dose of THC or a placebo, over roughly a month.

Their focus was a protein called mTOR — a kind of cellular “switch” that helps regulate metabolism and influences both cognitive performance and the aging process. They measured brain function and the levels of proteins involved in metabolism, memory, and synapse formation.

What They Found

In the older mice, long-term low-dose THC appeared to have an anti-aging effect on the brain — restoring cognitive abilities and synapse density. The effect on mTOR turned out to be what the researchers call “bidirectional”: in the brain, THC first increased mTOR activity (which supports the formation of new synapses), then later decreased it (which is associated with general anti-aging effects). The brain effects peaked around two weeks into the 28-day study. Outside the brain, in fat tissue, THC reduced mTOR activity throughout. The researchers suggested this dual, tissue-dependent effect could in principle be the basis for an anti-aging and cognition-enhancing drug.

An Important Detail: It Wasn't Good for Everyone

Here's a finding that deserves real emphasis, because it complicates the headline. The benefits appeared in old mice. The young mice given the same treatment showed slight memory impairment. In other words, the very same low-dose THC that seemed to help aged brains appeared to mildly harm young ones. This age-dependent split is consistent with earlier research and is a crucial caveat: THC's effects on the brain are not uniformly positive, and they appear to depend heavily on the age and state of the brain receiving them.

How to Read This

This is a thought-provoking study, but it's essential to keep it in proportion. It was conducted entirely in mice. The path from a result like this to a proven human treatment is long, and most promising animal findings do not translate directly to people. The researchers themselves call for further research, including human trials, to work out questions of dosage, duration, and how to weigh any potential anti-aging benefit against the well-documented risks of long-term THC use.

So this isn't a reason to view THC as an anti-aging treatment — no such treatment exists, and the young-mouse results are a reminder that more is not better. What the study does offer is a genuinely interesting lead for scientists studying how the brain ages, and why the timing and dose of a compound can matter as much as the compound itself.

Reference: Bilkei-Gorzo A, et al. Bidirectional Effect of Long-Term Δ9-Tetrahydrocannabinol Treatment on mTOR Activity and Metabolome. ACS Pharmacology & Translational Science, 2024. DOI: 10.1021/acsptsci.4c00002.

This article is for general information only and is not medical advice. The findings described come from animal research and may not apply to humans. Please consult a qualified healthcare professional for guidance on cannabis use.